Citation: Li N, Zhou G, Zheng Y, Lv D, Zhu X, Wei P, et al. (2022) Effects of SGLT2 inhibitors on cardiovascular outcomes in patients with stage 3/4 CKD: A meta-analysis. PLoS ONE 17(1):
e0261986.
… [read more]